{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:52Z","timestamp":1756902172184,"version":"3.44.0"},"reference-count":19,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.5863\/1551-6776-30.2.294","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:48:31Z","timestamp":1745246911000},"page":"294-297","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Overdose Deaths Increase as the Fourth Wave of the Opioid Epidemic Creates a Perfect Storm"],"prefix":"10.5863","volume":"30","author":[{"given":"Jeremy R.","family":"Canfield","sequence":"first","affiliation":[{"name":"Ohio Attorney General\u2019s Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon E.","family":"Sprague","sequence":"additional","affiliation":[{"name":"Ohio Attorney General\u2019s Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"(26)","key":"i2331-348X-30-2-294-b01","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"721","article-title":"Illicitly manufactured fentanyl\u2013involved overdose deaths with detected xylazine\u2014United States, January 2019\u2013June 2022","volume":"72","author":"Kariisa","year":"2023","unstructured":"Kariisa M, O\u2019Donnell J, Kumar S, et al. Illicitly manufactured fentanyl\u2013involved overdose deaths with detected xylazine\u2014United States, January 2019\u2013June 2022. MMWR Morb Mortal Wkly Rep. 2023;72(26):721\u2013727."},{"key":"i2331-348X-30-2-294-b02","unstructured":"Ohio Department of Health, Ohio Public Health Information Warehouse, Mortality Data. Accessed August 2024. URL"},{"issue":"(7)","key":"i2331-348X-30-2-294-b03","series-title":"JAMA Pediatr","first-page":"733","article-title":"National trends in pediatric deaths from fentanyl, 1999-2021","volume":"177","author":"Gaither","year":"2023","unstructured":"Gaither JR. National trends in pediatric deaths from fentanyl, 1999-2021. JAMA Pediatr. 2023;177(7):733\u2013735."},{"key":"i2331-348X-30-2-294-b04","series-title":"Clinical Toxicol","first-page":"1","article-title":"Trends in opioid exposures among young children reported to United States poison centers from 2016 to 2023","author":"Rosen","year":"2024","unstructured":"Rosen PE, Ramdin C, Leonard J, et al. Trends in opioid exposures among young children reported to United States poison centers from 2016 to 2023. Clinical Toxicol. 2024;1\u20138."},{"key":"i2331-348X-30-2-294-b05","unstructured":"Centers for Disease Control and Prevention. Understanding the opioid epidemic. Accessed August 2024. https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html","article-title":"Understanding the opioid epidemic"},{"issue":"(4)","key":"i2331-348X-30-2-294-b06","series-title":"Curr Opin Psychiatry","first-page":"344","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u2013350."},{"key":"i2331-348X-30-2-294-b07","unstructured":"United States Drug Enforcement Administration. One pill can kill. Accessed August 2024. https:\/\/www.dea.gov\/onepill","article-title":"One pill can kill"},{"key":"i2331-348X-30-2-294-b08","series-title":"Forensic Sci Int","first-page":"111414","article-title":"Genuine and counterfeit prescription pill surveillance in Washington, D.C","volume":"339","author":"Nguyen","year":"2022","unstructured":"Nguyen L, Evans A, Frank G, et al. Genuine and counterfeit prescription pill surveillance in Washington, D.C. Forensic Sci Int. 2022;339:111414."},{"key":"i2331-348X-30-2-294-b09","unstructured":"United States Drug Enforcement Administration. DEA warns of brightly-colored fentanyl used to target young Americans. Accessed August 2024. https:\/\/www.dea.gov\/press-releases\/2022\/08\/30\/dea-warns-brightly-colored-fentanyl-used-target-young-americans","article-title":"DEA warns of brightly-colored fentanyl used to target young Americans"},{"issue":"(Pt A)","key":"i2331-348X-30-2-294-b10","series-title":"Neuropharmacol","first-page":"121","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacol. 2018;134(Pt A):121\u2013132."},{"key":"i2331-348X-30-2-294-b11","series-title":"Drug Alcohol Depend","first-page":"107","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","unstructured":"Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107\u2013116."},{"key":"i2331-348X-30-2-294-b12","series-title":"Biochem Pharmacol","first-page":"114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","unstructured":"Eshleman AJ, Nagarajan S, Wolfrum KM, et al. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors. Biochem Pharmacol. 2020;182:114293."},{"issue":"(5)","key":"i2331-348X-30-2-294-b13","series-title":"J Mol Model","first-page":"144","article-title":"Molecular dynamics of fentanyl bound to \u03bc-opioid receptor","volume":"25","author":"Lipi\u0144ski","year":"2019","unstructured":"Lipi\u0144ski PF, Jaro\u0144czyk M, Dobrowolsk J, Sadlej, J. Molecular dynamics of fentanyl bound to \u03bc-opioid receptor. J Mol Model. 2019;25(5):144."},{"key":"i2331-348X-30-2-294-b14","series-title":"Forensic Sci Int","first-page":"110715","article-title":"Carfentanil\u2014from an animal anesthetic to a deadly illicit drug","volume":"320","author":"Zawilska","year":"2021","unstructured":"Zawilska JB, Kuczy\u0144ska K, Kosmal W, et al. Carfentanil\u2014from an animal anesthetic to a deadly illicit drug. Forensic Sci Int. 2021;320:110715."},{"issue":"(4)","key":"i2331-348X-30-2-294-b15","series-title":"J Forensic Sci","first-page":"1186","article-title":"Fentanyl-related substance scheduling as an effective drug control strategy","volume":"66","author":"Weedn","year":"2021","unstructured":"Weedn VW, Elizabeth Zaney M, McCord B, et al. Fentanyl-related substance scheduling as an effective drug control strategy. J Forensic Sci. 2021;66(4):1186\u20131200."},{"key":"i2331-348X-30-2-294-b16","series-title":"Cureus","first-page":"e40736","article-title":"Old drugs and new challenges: a narrative review of nitazenes","volume":"15","author":"Pergolizzi,","year":"2023","unstructured":"Pergolizzi, J, Raffa R, LeQuang JA, et al. Old drugs and new challenges: a narrative review of nitazenes. Cureus. 2023;15:e40736."},{"key":"i2331-348X-30-2-294-b17","unstructured":"United States Drug Enforcement Administration. Benzimidazole-opioids other name: nitazenes. Accessed August 2024. https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/benzimidazole-opioids.pdf","article-title":"Benzimidazole-opioids other name: nitazenes"},{"issue":"(7)","key":"i2331-348X-30-2-294-b18","series-title":"ACS Chem Neurosci","first-page":"1241","article-title":"Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids","volume":"12","author":"Vandeputte","year":"2021","unstructured":"Vandeputte MM, Van Uytfanghe K, Layle NK, et al. Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids. ACS Chem Neurosci. 2021;12(7):1241\u20131251."},{"key":"i2331-348X-30-2-294-b19","unstructured":"Drugs.com. Accessed August 2024."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/2\/article-p294.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/2\/article-p294.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/30\/2\/article-p294.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:48:31Z","timestamp":1745246911000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/30\/2\/article-p294.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-30.2.294","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}